GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.0837
-0.0037 (-4.23%)
Oct 2, 2026, 5:35 PM CET

GenSight Biologics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
20233326155255
Market Cap Growth
-28.28%-30.35%28.79%-83.46%-39.23%-16.09%
Enterprise Value
31424946147220
Last Close Price
0.080.100.270.463.365.56

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-78.1935.3112.598.6631.9033.13
PB Ratio
-0.58-0.92-1.23-0.84-10.1615.97
P/TBV Ratio
-----16.09

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-64.0518.5915.5330.2528.53

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.38-0.52-0.53-0.77-1.171.10
Net Debt / Equity Ratio
-0.33-0.42-0.44-0.70-0.47-1.67
Net Debt / EBITDA Ratio
-0.88-0.95-0.81-0.78-0.270.99
Net Debt / FCF Ratio
-1.34-1.14-0.92-0.87-0.211.56
Asset Turnover
-0.070.260.170.120.15
Quick Ratio
0.140.320.200.180.962.18
Current Ratio
0.350.390.240.261.572.40
Return on Equity (ROE)
-----7781.69%-206.34%
Return on Assets (ROA)
-115.69%-72.68%-99.39%-105.83%-42.13%-33.80%
Return on Capital Employed (ROCE)
239.00%250.50%133.30%183.80%-246.30%-81.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-78.16%-52.29%-42.36%-102.16%-17.80%-11.21%
FCF Yield
-42.48%-39.85%-39.14%-96.14%-21.91%-6.72%
Buyback Yield / Dilution
-46.21%-54.91%-98.18%-4.29%-2.61%-28.54%